Your Ypê cleaning products with batch numbers ending in 1 have been banned from manufacturing and sales since May 7 — and may return to shelves on Friday, when Anvisa judges the company's appeal. The National Health Surveillance Agency found Pseudomonas aeruginosa bacteria in over 100 batches during an inspection conducted in April at the Química Amparo Ltda factory (CNPJ 43.461.789/0001-90) in Amparo-SP, according to director-president Leandro Safatle. ✓
Press quotes (2)
"De acordo com Safatle, em fiscalização realizada em abril deste ano, as equipes da Anvisa, em conjunto com o Centro de Vigilância Sanitária do Estado de São Paulo e a Vigilância Municipal de Amparo, encontraram 76 irregularidades na unidade, como a presença da bactéria Pseudomonas aeruginosa em mais de 100 lotes."
"1. Empresa: QUÍMICA AMPARO LTDA - CNPJ: 43.461.789/0001-90"
The company appealed the suspension and the judgment, scheduled for Wednesday (13), was postponed to Friday (15) at 9:30 AM. Química Amparo committed to presenting a new action plan on Thursday (14) to correct the irregularities. "The company presented the investments already made, intensified efforts to address the irregularities," Safatle said during an Anvisa Board of Directors meeting.
Press quotes (1)
"RESOLUÇÃO-RE nº 1.834, DE 05 DE MAIO DE 2026"
Pseudomonas aeruginosa is an antibiotic-resistant bacterium that rarely infects healthy people but can cause serious conditions in individuals with compromised immune systems — from urinary infections to respiratory problems in people with chronic lung diseases, according to medical literature cited by the press. ✓
Press quotes (2)
"A diretoria da Agência Nacional de Vigilância Sanitária (Anvisa) adiou nesta quarta-feira (13) a análise do recurso apresentado pela Química Amparo"
"A empresa apresentou os investimentos já realizados, intensificou os esforços para adequação das irregularidades e se comprometeu a apresentar medidas para a correção dessas ações amanhã, dia 14 de maio de 2026"
Covered by only some sources, or where the accounts diverge.
-
What concentrations of Pseudomonas aeruginosa bacteria were found versus permitted regulatory limits?
Why it's still unknown: Anvisa has not released specific technical data about detected bacterial concentrations or how they compare to RDC 47/2013 standards.
-
What is the specific legal basis cited in Resolution RE No. 1,834 for ordering the recall?
Why it's still unknown: Attempt to obtain the complete text of the resolution in the Official Gazette showed only the preamble, without access to the considerations justifying the measure.
-
Were there documented cases of consumers infected by bacteria present in Ypê products?
Why it's still unknown: Neither Anvisa nor the press reported whether there are notifications of infections related to the use of contaminated products.
-
What other companies in the sector have suffered similar measures from Anvisa for bacterial contamination in recent years?
Why it's still unknown: There is no information about regulatory precedents that would allow contextualizing the severity of the measure against Ypê in the agency's enforcement history.